Warning: The NCBI web site requires JavaScript to function. more...
Gene therapy of the rheumatic diseases: 1998 to 2008.
Evans CH, Ghivizzani SC, Robbins PD.
Arthritis Res Ther. 2009;11(1):209. Epub 2009 Jan 30. Review.
Related citations
Gene therapy: what have we accomplished and where do we go from here?
Evans CH.
J Rheumatol Suppl. 2005 Jan;72:17-20. Review.
The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics.
Evans CH, Ghivizzani SC, Gouze E, Rediske JJ, Schwarz EM, Robbins PD.
Arthritis Res Ther. 2005;7(6):273-8. Epub 2005 Oct 28.
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
[No authors listed]
Drugs R D. 2007;8(3):176-87. Review.
Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
Drugs R D. 2003;4(5):306-9. Review.
Gene therapy: a brief overview of the past, present, and future.
Scollay R.
Ann N Y Acad Sci. 2001 Dec;953:26-30. Review.
Gene therapy in autoimmune diseases: challenges and opportunities.
Leung PS, Dhirapong A, Wu PY, Tao MH.
Autoimmun Rev. 2010 Jan;9(3):170-4. Epub 2009 Oct 23. Review.
Getting arthritis gene therapy into the clinic.
Nat Rev Rheumatol. 2011 Apr;7(4):244-9. Epub 2010 Dec 7.
The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer.
Gillet JP, Macadangdang B, Fathke RL, Gottesman MM, Kimchi-Sarfaty C.
Methods Mol Biol. 2009;542:5-54. Review.
Gene therapy for rheumatoid arthritis.
Gouze E, Ghivizzani SC, Robbins PD, Evans CH.
Curr Rheumatol Rep. 2001 Feb;3(1):79-85. Review.
Clinical trials in the gene therapy of arthritis.
Evans CH, Ghivizzani SC, Herndon JH, Wasko MC, Reinecke J, Wehling P, Robbins PD.
Clin Orthop Relat Res. 2000 Oct;(379 Suppl):S300-7.
Gene therapy for autoimmune disorders.
Evans CH, Ghivizzani SC, Oligino TJ, Robbins PD.
J Clin Immunol. 2000 Sep;20(5):334-46. Review.
Gouze E, Ghivizzani SC, Palmer GD, Gouze JN, Robbins PD, Evans CH.
Expert Opin Biol Ther. 2001 Nov;1(6):971-8. Review.
What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases.
Oliver JE, Silman AJ.
Arthritis Res Ther. 2009;11(3):223. Epub 2009 May 19.
Gene therapy for rheumatoid arthritis: recent advances.
Woods JM, Sitabkhan Y, Koch AE.
Curr Gene Ther. 2008 Feb;8(1):24-41. Review.
INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs. 2003;17(3):216-22. Review.
[Development of antituberculous drugs: current status and future prospects].
Tomioka H, Namba K.
Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.
The story so far in R&D.
Prous JR, Khurdayan VK.
Drug News Perspect. 2007 Jan-Feb;20(1):7-15.
The road toward human gene therapy--a 25-year perspective.
Friedmann T.
Ann Med. 1997 Dec;29(6):575-7.
Transcription profiling of rheumatic diseases.
van Baarsen LG, Bos CL, van der Pouw Kraan TC, Verweij CL.
Arthritis Res Ther. 2009;11(1):207. Epub 2009 Jan 30. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on